.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The VA National Acquisition Center (NAC) intends to issue RFP 36E79726R0004 for Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The award will be a single contract to a responsible offeror to provide uninterrupted supply, for a base period of one year plus four pre-priced one-year option periods, with distribution through the VA’s and DOD’s Pharmaceutical Prime Vendor Programs. The solicitation was to be electronically issued on or about 2026-01-05 with a tentative closing (response) date of 2026-01-19; estimated annual requirements and formulation sizes are listed in the posting.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
No files attached to this RFP.
Many agencies add documentation later or require FOIA requests. Starbridge can automatically retrieve these files for you.
The VA National Acquisition Center intends to issue RFP 36E79726R0004 for an unrestricted procurement of Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs and other federal customers (DOD, BOP, IHS). The award will be a single contract for one year plus four one-year option periods, with distribution through VA and DOD Pharmaceutical Prime Vendor Programs and specific packaging/NDC requirements. The solicitation was published 2025-12-31 and has a tentative electronic issue date about 2026-01-05 with a response/closing date of 2026-01-19.
Posted Date
Dec 31, 2025
Due Date
Jan 19, 2026
Release: Dec 31, 2025
Close: Jan 19, 2026
The VA National Acquisition Center intends to issue RFP 36E79726R0004 for an unrestricted procurement of Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs and other federal customers (DOD, BOP, IHS). The award will be a single contract for one year plus four one-year option periods, with distribution through VA and DOD Pharmaceutical Prime Vendor Programs and specific packaging/NDC requirements. The solicitation was published 2025-12-31 and has a tentative electronic issue date about 2026-01-05 with a response/closing date of 2026-01-19.
AvailableThe Department of Veterans Affairs National Acquisition Center solicits offers for Buprenorphine HCL/Naloxone HCL sublingual tablets in two strengths (2mg/0.5mg and 8mg/2mg) supplied in 30-count bottles to establish a supply source through VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must meet FDA requirements, provide a unique 11-digit NDC, submit a manufacturer Letter of Commitment, and include pricing that accounts for a mandatory 0.5% Cost Recovery Fee for the base year and four option years. The contract is unrestricted (small business size standard 1,300 employees), serves multiple federal healthcare agencies via prime vendor distributors, and had offers due Jan 20, 2026.
Posted Date
Jan 6, 2026
Due Date
Jan 20, 2026
Release: Jan 6, 2026
Close: Jan 20, 2026
Provide Buprenorphine HCL/Nalaxone HCL Tablets. Description Size Estimated Annual Requirements (Bottle) BuprenorphineHCL 2mg/Naloxone HCL 0.5mg Tab, Sublingual 30 171,239 BuprenorphineHCL 8mg/Naloxone HCL 2mg Tab, Sublingual 30 251,144.
Posted Date
Dec 31, 2025
Due Date
Jan 19, 2026
Release: Dec 31, 2025
Close: Jan 19, 2026
Provide Buprenorphine HCL/Nalaxone HCL Tablets. Description Size Estimated Annual Requirements (Bottle) BuprenorphineHCL 2mg/Naloxone HCL 0.5mg Tab, Sublingual 30 171,239 BuprenorphineHCL 8mg/Naloxone HCL 2mg Tab, Sublingual 30 251,144.
AvailableThis is a pre‑solicitation notice for the Bunton Creek Road Improvement project (Lehman Road to Porter Cove) that will include intersection improvements, widening travel lanes, upgrades to pedestrian and bicycle facilities, and construction of a new roundabout at Bunton Creek Road & Goforth Road. The posting on the City of Kyle procurement portal is explicitly a notice (no contract will be awarded from this posting) and lists an offers due date for when the solicitation is expected (Jan 31, 2026). Project documents/100% plans are listed on the procurement portal downloads but full solicitation documents are not publicly downloadable without portal access.
Posted Date
Dec 18, 2025
Due Date
Jan 31, 2026
Release: Dec 18, 2025
Close: Jan 31, 2026
This is a pre‑solicitation notice for the Bunton Creek Road Improvement project (Lehman Road to Porter Cove) that will include intersection improvements, widening travel lanes, upgrades to pedestrian and bicycle facilities, and construction of a new roundabout at Bunton Creek Road & Goforth Road. The posting on the City of Kyle procurement portal is explicitly a notice (no contract will be awarded from this posting) and lists an offers due date for when the solicitation is expected (Jan 31, 2026). Project documents/100% plans are listed on the procurement portal downloads but full solicitation documents are not publicly downloadable without portal access.
Surface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The Department of Veterans Affairs National Acquisition Center solicits offers for Buprenorphine HCL/Naloxone HCL sublingual tablets in two strengths (2mg/0.5mg and 8mg/2mg) supplied in 30-count bottles to establish a supply source through VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must meet FDA requirements, provide a unique 11-digit NDC, submit a manufacturer Letter of Commitment, and include pricing that accounts for a mandatory 0.5% Cost Recovery Fee for the base year and four option years. The contract is unrestricted (small business size standard 1,300 employees), serves multiple federal healthcare agencies via prime vendor distributors, and had offers due Jan 20, 2026.
Available